289 related articles for article (PubMed ID: 32892987)
21. Amplatzer left atrial appendage occlusion: single center 10-year experience.
Nietlispach F; Gloekler S; Krause R; Shakir S; Schmid M; Khattab AA; Wenaweser P; Windecker S; Meier B
Catheter Cardiovasc Interv; 2013 Aug; 82(2):283-9. PubMed ID: 23412815
[TBL] [Abstract][Full Text] [Related]
22. Left Atrial Appendage Transcatheter Occlusion with AMPLATZER™ Amulet™ Device: Real Life Data with Mid-Term Follow-Up Results.
Şahiner ML; Kaya EB; Çöteli C; Aytemir K
Arq Bras Cardiol; 2019; 113(4):712-721. PubMed ID: 31365601
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation.
Lee OH; Kim JS; Pak HN; Hong GR; Shim CY; Uhm JS; Cho IJ; Joung B; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Jang Y
Am J Cardiol; 2018 Jun; 121(12):1534-1539. PubMed ID: 29631803
[TBL] [Abstract][Full Text] [Related]
24. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
[TBL] [Abstract][Full Text] [Related]
25. Meta-Analysis of Usefulness of Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack.
Medranda GA; Zhang C; Doros G; Yerasi C; Case BC; Weintraub WS; Waksman R
Am J Cardiol; 2021 Aug; 153():129-134. PubMed ID: 34226040
[TBL] [Abstract][Full Text] [Related]
26. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653
[TBL] [Abstract][Full Text] [Related]
27. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
[TBL] [Abstract][Full Text] [Related]
28. Rationale and design for the randomized placebo-controlled double-blind trial studying the effect of single antiplatelet therapy (clopidogrel) versus dual antiplatelet therapy (clopidogrel/acetylsalicylic acid) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty (CLEAR-PATH).
Wegerif ECJ; Ünlü Ç; Generaal MI; van den Bor RM; van de Ven PM; Bots ML; de Borst GJ
Am Heart J; 2024 Jul; 273():121-129. PubMed ID: 38608997
[TBL] [Abstract][Full Text] [Related]
29. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
[TBL] [Abstract][Full Text] [Related]
30. Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.
Duthoit G; Silvain J; Marijon E; Ducrocq G; Lepillier A; Frere C; Dimby SF; Popovic B; Lellouche N; Martin-Toutain I; Spaulding C; Brochet E; Attias D; Mansourati J; Lorgis L; Klug D; Zannad N; Hauguel-Moreau M; Braik N; Deltour S; Ceccaldi A; Wang H; Hammoudi N; Brugier D; Vicaut E; Juliard JM; Montalescot G
Circ Cardiovasc Interv; 2020 Jul; 13(7):e008481. PubMed ID: 32674675
[TBL] [Abstract][Full Text] [Related]
31. Outcome of left atrial appendage occlusion in high-risk patients.
Masoud A; Bartoletti S; Fairbairn T; Khurana A; Velavan P; Morrison WL; Khalatbari A; Aggarwal S; Sharma N; Kirchhof P; Gupta D
Heart; 2018 Apr; 104(7):594-599. PubMed ID: 29122931
[TBL] [Abstract][Full Text] [Related]
32. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
[TBL] [Abstract][Full Text] [Related]
33. Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity: Results of the CREATIVE Trial.
Tang YD; Wang W; Yang M; Zhang K; Chen J; Qiao S; Yan H; Wu Y; Huang X; Xu B; Gao R; Yang Y;
Circulation; 2018 May; 137(21):2231-2245. PubMed ID: 29420189
[TBL] [Abstract][Full Text] [Related]
34. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
35. Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
van Diepen S; Fuster V; Verma S; Hamza TH; Siami FS; Goodman SG; Farkouh ME
J Am Coll Cardiol; 2017 Jan; 69(2):119-127. PubMed ID: 28081820
[TBL] [Abstract][Full Text] [Related]
36. Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk.
Brockmeyer M; Wolff G; Krieger T; Lin Y; Karathanos A; Afzal S; Zeus T; Westenfeld R; Polzin A; Heinen Y; Perings S; Kelm M; Schulze V
Acta Cardiol; 2020 Aug; 75(4):312-320. PubMed ID: 30983505
[No Abstract] [Full Text] [Related]
37. Left atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study.
Fastner C; Behnes M; Sartorius B; Yildiz M; Mashayekhi K; El-Battrawy I; Lehmann R; Baumann S; Becher T; Borggrefe M; Akin I
BMC Cardiovasc Disord; 2016 Jan; 16():25. PubMed ID: 26822890
[TBL] [Abstract][Full Text] [Related]
38. Meta-Analysis Comparing Single Versus Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation.
Maes F; Stabile E; Ussia GP; Tamburino C; Pucciarelli A; Masson JB; Marsal JR; Barbanti M; Côté M; Rodés-Cabau J
Am J Cardiol; 2018 Jul; 122(2):310-315. PubMed ID: 29861051
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
[TBL] [Abstract][Full Text] [Related]
40. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
López-Mínguez JR; Nogales-Asensio JM; Infante De Oliveira E; De Gama Ribeiro V; Ruiz-Salmerón R; Arzamendi-Aizpurua D; Costa M; Gutiérrez-García H; Fernández-Díaz JA; Martín-Yuste V; Rama-Merchán JC; Moreno-Gómez R; Benedicto-Buendía A; Íñiguez-Romo A
Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):449-455. PubMed ID: 29754808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
